The behavioural pharmacology of anxiety and depression

Impacts of Coastal Development on the Ecology of Tidal Creek Ecosystems of the US Southeast including Consequences to Humans.

Estuaries and coasts : journal of the Estuarine Research Federation·2019

One-stop microvascular screening service: an effective model for the early detection of diabetic peripheral neuropathy and the high-risk foot.

Diabetic medicine : a journal of the British Diabetic Association·2018

'It's made all of us bond since that course…' - a qualitative study of service users' experiences of a CBT anger management group intervention.

Journal of intellectual disability research : JIDR·2014

Cognitive behavioural anger management intervention for people with intellectual disabilities: costs of intervention and impact on health and social care resource use.

Journal of intellectual disability research : JIDR·2014

A cluster randomised controlled trial of a manualised cognitive behavioural anger management intervention delivered by supervised lay therapists to people with intellectual disabilities.

Health technology assessment (Winchester, England)·2013

Loss of social status: preliminary evaluation of a novel animal model of depression.

Journal of psychopharmacology (Oxford, England)·2012

Direct comparison of the effects of functionally equivalent dosing regimens of methamphetamine, methcathinone, and α-pyrrolidinopropiophenone on behavioral and neurochemical markers of stimulant-induced neurotoxicity.

Behavioural pharmacology·2026

Drug-specific effects of anxiety on high-dose oxycodone: age as a modifier for oxycodone response.

Behavioural pharmacology·2026

Polygalic acid produces rapid antidepressant effects via modulation of hippocampal inflammation and brain-derived neurotrophic factor expression in mice.

Behavioural pharmacology·2026

Behavioral and pharmacological validation of the differential reinforcement of low-rate behavior paradigm in non-human primates.

Behavioural pharmacology·2026

Sex-dependent analgesic effects of phoenixin-14 on mechanical allodynia in mouse models of neuropathic and inflammatory pain.

Behavioural pharmacology·2026

Conditioned place preference and conditioned place aversion in goldfish.

Behavioural pharmacology·2026

Comparative Efficacy and Safety of Tirzepatide Versus Semaglutide for Obesity: A Systematic Review.

Cureus·2026

Revisiting Fulvestrant Dosing: Biomarker-Driven Computational PK/PD Modeling and Dosing Optimization in Estrogen Receptor-Positive Breast Cancer.

Mathematical biosciences·2026

Polypharmacy and Deprescribing Patterns in an Australian Palliative Care Unit: A Cohort Study.

Journal of pain and symptom management·2026

PLGA nanoparticles for the delivery of antimicrobial peptides in a polymicrobial sepsis model.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026

Laying the groundwork for future health economic evaluation of [18F]PSMA PET/CT in guiding treatment decisions for metastatic castration-resistant prostate cancer patients.

European journal of radiology·2026

Deprescribing interventions in older adults with cancer: A systematic review and meta-analysis.

Journal of geriatric oncology·2026

Related Experiment Videos

The behavioural pharmacology of anxiety and depression

Related Concept Videos

Impacts of Coastal Development on the Ecology of Tidal Creek Ecosystems of the US Southeast including Consequences to Humans.

One-stop microvascular screening service: an effective model for the early detection of diabetic peripheral neuropathy and the high-risk foot.

'It's made all of us bond since that course…' - a qualitative study of service users' experiences of a CBT anger management group intervention.

Cognitive behavioural anger management intervention for people with intellectual disabilities: costs of intervention and impact on health and social care resource use.

A cluster randomised controlled trial of a manualised cognitive behavioural anger management intervention delivered by supervised lay therapists to people with intellectual disabilities.

Loss of social status: preliminary evaluation of a novel animal model of depression.

Direct comparison of the effects of functionally equivalent dosing regimens of methamphetamine, methcathinone, and α-pyrrolidinopropiophenone on behavioral and neurochemical markers of stimulant-induced neurotoxicity.

Drug-specific effects of anxiety on high-dose oxycodone: age as a modifier for oxycodone response.

Polygalic acid produces rapid antidepressant effects via modulation of hippocampal inflammation and brain-derived neurotrophic factor expression in mice.

Behavioral and pharmacological validation of the differential reinforcement of low-rate behavior paradigm in non-human primates.

Sex-dependent analgesic effects of phoenixin-14 on mechanical allodynia in mouse models of neuropathic and inflammatory pain.

Conditioned place preference and conditioned place aversion in goldfish.

Comparative Efficacy and Safety of Tirzepatide Versus Semaglutide for Obesity: A Systematic Review.

Revisiting Fulvestrant Dosing: Biomarker-Driven Computational PK/PD Modeling and Dosing Optimization in Estrogen Receptor-Positive Breast Cancer.

Polypharmacy and Deprescribing Patterns in an Australian Palliative Care Unit: A Cohort Study.

PLGA nanoparticles for the delivery of antimicrobial peptides in a polymicrobial sepsis model.

Laying the groundwork for future health economic evaluation of [18F]PSMA PET/CT in guiding treatment decisions for metastatic castration-resistant prostate cancer patients.

Deprescribing interventions in older adults with cancer: A systematic review and meta-analysis.

Related Experiment Videos

The behavioural pharmacology of anxiety and depression

Related Concept Videos

Related Articles